Search Options Stock News and Analysis from Schaeffer's

Sanofi Suspends mRNA Vaccine Development Amid Stiff Competition

https://www.schaeffersresearch.com/content/news/2021/09/28/sanofy-suspends-mrna-vaccine-development-amid-stiff-competition

9/28/2021 10:03 AM

Sanofi SA (NASDAQA:SNY) announced that it will be suspending any further developments of its mRNA-based Covid-19 vaccine, despite positive results in its last study, as inoculations from Moderna (MRN...

Expedited COVID-19 Trials Give REGN a Boost

https://www.schaeffersresearch.com/content/news/2020/07/06/expedited-covid-19-trials-give-regn-a-boost

7/6/2020 9:41 AM

Biotech Regeneron Pharmaceuticals Inc (NASDAQ:REGN) is getting a boost this morning after news that it's starting phase 3 trials for its antibody drug cocktail to treat COVID-19. This trial comes jus...

SNY Stock Pops on First-Quarter Results

https://www.schaeffersresearch.com/content/news/2020/04/24/sny-stock-pops-on-first-quarter-results

4/24/2020 10:06 AM

French pharmaceutical maker Sanofi SA (NASDAQ:SNY) is up 2.2% at $49.45 after releasing its first-quarter results and confirming its 2020 outlook. The company announced a 16.1% rise in income at cons...

Alnylam Pharmaceuticals Put Buyers Take Profits During Slide

https://www.schaeffersresearch.com/content/options/2019/05/03/alnylam-pharmaceuticals-put-buyers-take-profits-during-slide

5/3/2019 1:49 PM

Amid an up day in the broader equities market, the shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) are trading 6.4% lower at $77.25, on news Sanofi (SNY) divested its roughly 10% stake in the ...

4 Biotech Stocks Moving on Buyout Buzz

https://www.schaeffersresearch.com/content/news/2018/01/22/4-biotech-stocks-moving-on-buyout-buzz

1/22/2018 10:58 AM

Juno Therapeutics Inc (NASDAQ:JUNO) agreed to be bought out by Celgene Corporation (NASDAQ:CELG), confirming last week's reports in the Wall Street Journal. CELG already owns a 9.7% stake in JUNO, b...

PEOPLE ALSO SEARCH FOR